Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Mutant Protein Developed By Hebrew University Scientists

17.03.2005


A unique technique for neutralizing the action of the leptin protein in humans and animals – thereby providing a means for controlling and better understanding of leptin function, including its role in unwanted cell growth -- has been developed by researchers at the Hebrew University of Jerusalem.


Three-dimensional structure of leptin. The region identified in the picture by numbers as amino acids 39, 40, 41, 42 underwent mutation that converted the normal leptin into an “antagonistic” version.



Leptin was discovered ten years ago and has attracted attention first because of its involvement in control of appetite and later by its effect on growth, puberty, digestion and immunological processes. Leptin can also have negative consequences, such as, for example, enhancing the spread of tumorous growths.

In his laboratory at the Hebrew University’s Faculty of Agricultural Food and Environmental Quality Sciences in Rehovot, Arieh Gertler, the Karl Bach Professor of Agricultural Biochemistry, along with his students, has developed a technique for genetically engineering mutations of the leptin protein. Prof. Gertler has been assisted in this work by graduate students Dana Gonen-Berger and Leonora Niv-Spector.and research assistant Gili Benyehuda.


In experimental work carried out cooperatively with researchers at the Agronomic Research Institute of France and the University of Paris VI, the scientists have developed a model showing which amino acids in leptin are responsible for activating leptin receptors in living cells. By replacing these amino acids with others, they were able to create a leptin variant that could bind with cell receptors, but would be unable to activate them, thereby providing a unique, novel research tool. In this way, the mutated leptin, with the substituted amino acids, acts as an “antagonist,” competing with the normal leptin for the “attention” of the cell receptors to which both leptins are attracted. The result is a “standoff” situation in which the normal leptin is neutralized.

Since leptin is involved in several cell functions, the development of this mutated “antagonistic leptin” could have significant consequences not only for better understanding of leptin action in animals but also on halting undesirable leptin effects in humans, such as undesired cell proliferation in cancer, or in controlling other pathological phenomena in which leptin is a factor.

Thus far, the researchers have succeeded in creating antagonists of human, sheep, rat and mouse leptins.

A company, Protein Laboratories Rehovot (PLR), that was formed by Prof. Gertler and the Hebrew University’s Yissum Research Development Company 18 months ago, was given the license to produce and market the mutated leptin products. Further development is currently being pursued towards testing whether leptin antagonists are capable of anti-cancer activity. This work is being pursued in cooperation with Prof. Nira Ben-Jonathan of the University of Cincinnati in the U.S., with the assistance of Prof. Gertler’s graduate student, Gila Ben Avraham.

Prof. Gertler has presented his work at a symposium of the Israeli Endocrinology Society and most recently at an international biotechnological conference in Miami, Fla., sponsored by the scientific journal Nature.

Jerry Barach | alfa
Further information:
http://www.huji.ac.il

More articles from Life Sciences:

nachricht Closing the carbon loop
08.12.2016 | University of Pittsburgh

nachricht Newly discovered bacteria-binding protein in the intestine
08.12.2016 | University of Gothenburg

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

Closing the carbon loop

08.12.2016 | Life Sciences

Applicability of dynamic facilitation theory to binary hard disk systems

08.12.2016 | Physics and Astronomy

Scientists track chemical and structural evolution of catalytic nanoparticles in 3-D

08.12.2016 | Materials Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>